Clinical characteristics of anhedonia in Japanese patients with parkinson's disease

International Medical Journal

Volumn 18, Issue 3, 2011, Pages 185-187

  Harada, Toshihide ^a   Ishizaki, Fumiko ^a   Horie, Nobuko ^b   Katsuoka, Hiroyuki ^c   Nitta, Yumiko ^d   Yamada, Tohru ^e   Nitta, Kohsaku ^f  

^a PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^b National Hospital Organization   (Japan)

^c HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^d Suzugamine Women's College   (Japan)

^e Yamada Memorial Hospital   (Japan)

^f NONE   (Japan)

Author keywords

Anhedonia; Parkinson's disease; SHAPS

Indexed keywords

AMANTADINE; CABERGOLINE; DICHLORISOPRENALINE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; SELEGILINE; THREO 3,4 DIHYDROXYPHENYLSERINE;

AGED; ANHEDONIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; FEMALE; HUMAN; JAPANESE; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PSYCHOANALYSIS; PSYCHOPHARMACOLOGY; SNAITH HAMILTON PLEASURE SCALE; WESTERN HEMISPHERE;

EID: 80053551235     PISSN: 13412051     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Brown RG. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 1988; 18: 49-55. (Pubitemid 18071632)
2. Dooneief G. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992; 49: 305-307.
3. Harada T, Ishizaki F, Tachiki N, Matsumoto T, Horie N, Inoue K. Circadian rhythm of cardiovascular autonomic function in Parkinson's disease and multiple system atrophy. International Medical Journal (IMJ) 2005; 12: 37-39. (Pubitemid 40637213)
4. Harada T, Ishizaki F, Murata Y, Mitsuoka K, Kumagai R, Nitta K. Clinical characteristics of neuroleptic malignant syndrome in Parkinson's disease and other neurological disorders. International Medical Journal (IMJ) 2001; 8: 249-258.
5. Velikova G, Selby PJ, Snaith PR. The relationship of cancer pain to anxiety. Psychother Psychosom 1995; 63: 181-184.
6. Lemke MR, Brecht HM, Koester J, Reichmann H. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. J Neurol Sci 2006; 248 (1/2): 266-270. (Pubitemid 44754866)
7. Harada T, Ishizaki F, Tachiki N, Nitta K, Horie N, Matsumoto T. Evaluation of cardiovascular circadian rhythm in patients with Parkinson's disease. International Medical Journal (IMJ) 2001; 8: 269-274. (Pubitemid 34131978)
8. Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease (2001). Treat Neurol 2001; 56: 1-88.
9. Hasler G, Drevets WC, Manji HK, Charney DS. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004; 29: 1765-1781. (Pubitemid 39336788)
10. Dryman A, Eaton WW. Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program. Acta Psychiatr Scand 1991 84: 1-5.